Electrophysiology & Arrhythmia

After adjusting for multiple variables, adults who abused alcohol had increased risks of atrial fibrillation, MI and congestive heart failure, according to a longitudinal analysis. The relative risk for those outcomes were highest in adults who had no established cardiovascular risk factors.

Studies have shown that small amounts of alcohol could reduce the incidence of coronary disease. However, a recent review found that the benefits of alcohol do not apply to atrial fibrillation. In fact, the researchers noted that alcohol was a risk factor for atrial fibrillation, also known as an irregular heartbeat.

Though marijuana is now prescribed by medical professionals to help some patients cope with their health conditions, a new study shows that the drug could still do harm if used too frequently.

More than 95 percent of implantations with the Watchman device for left atrial appendage occlusion in patients with non-valvular atrial fibrillation were successful, according to an analysis of procedural data.

Based on their findings, the researchers mentioned that EMRs could be used to evaluate existing prediction models and develop new models and be incorporated into clinical practice to prospectively identify people at high risk of atrial fibrillation and other diseases.

More communities have started to place AEDs in public locations. Still, a recent Canadian study showed those initiatives might not be enough to provide people with a better chance to survive cardiac arrests.

A recent retrospective, population-based cohort study in Canada showed that proximity to an AED might not always lead to using the device. More than 20 percent of out-of-hospital cardiac arrests occurred near a public AED that was inaccessible at the time of the arrest.

The American College of Cardiology (ACC) and American Heart Association (AHA) released updated clinical performance and quality measure sets on June 27 for adults with atrial fibrillation or atrial flutter.

Five electrophysiologists joined Cardiovascular Business editorial advisor Matthew R. Reynolds, MD, SM, for a discussion about how they will deliver quality care to a growing number of atrial fibrillation patients even as the U.S. healthcare system turns its focus from volume to value.

Patients with systolic heart failure who received a novel technology using the SonR hemodynamic sensor were more likely to respond to cardiac resynchronization therapy (CRT) compared with those who used echocardiographic optimization, according to a prospective trial. Patients in the SonR group also had a statistically significant, 35 percent reduction in heart failure-related hospitalizations.

An FDA advisory panel recommended against the approval of the AngelMed Guardian system, an implantable cardiac monitor, designed to detect rapid changes in the heart’s electrical signal caused by a coronary artery occlusion.

A disconnect between best care and what Medicare is willing to reimburse for it has put some electrophysiologists and their hospitals in a bind.